E2F6 Recombinant Antibody, RBITC Conjugated
Product Specifications
Background
Inhibitor of E2F-dependent transcription. Binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3'. Has a preference for the 5'-TTTCCCGC-3' E2F recognition site. E2F-6 lacks the transcriptional activation and pocket protein binding domains.
Synonyms
E2F 6; E2F-6; E2F6; EMA.
Gene ID
1876
Swiss Prot
O75461
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human
Target
E2F6
Clonality
Recombinant
Isotype
IgG
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human E2F6
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1876
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038535-FITC 200 µL
MOGT3, CT (MOGAT3, DC7, DGAT2L7, 2-acylglycerol O-acyltransferase 3, Acyl-CoA:monoacylglycerol acyltransferase 3, Diacylglycerol O-acyltransferase candidate 7, Diacylglycerol acyltransferase 2-like protein 7, Monoacylglycerol O-acyltransferase 3) (FITC) discontinued
Sign In for Pricing
View Details